Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 3,460.00
+150.00 (4.53%)
At close: Jul 31, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 44.05 billion as of July 31, 2026. Its market cap has decreased by -37.44% in one year.
Market Cap
44.05B
Enterprise Value
58.55B
Revenue
108.27B
Ranking
n/a
PE Ratio
193.09
Stock Price
3,460.00
ChartMarket Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 44.05B, a decrease of -70.72%. That is a compound annual growth rate of -13.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 44.05B | -12.83% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynamic solution | 71.89B |
| L&K Biomed | 68.28B |
| Hironic | 61.73B |
| SELVAS Healthcare | 61.21B |
| DRGEM | 53.61B |
| JPI Healthcare | 44.42B |
| QuantaMatrix | 40.03B |
| Genesystem | 39.19B |